PD-L1 Biomarker Testing Market Opportunities, Trends, and Forecast by 2030 | Future Market Insights Report

1
PD-L1 Biomarker Testing Market Research by
Competitive Landscape, latest trends, Global
Forecast 2021 To 2030 FMI

• March 2021

Report Id    REP-GB-5897Published On
2020-10-16Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
PD-L1 Biomarker Testing Market Analysis
The pd l1 biomarker testing market is showing a
positive growth trajectory due to accelerated
tracking of diseases and their associated
treatment. According to new research market for
PDL1 biomarker testing market, conducted by
Future Market Insights (FMI), adoption of PDL1
will remain strong in the US and Europe during
the course of the forecast period. "Market
players are constantly focussing on
cost-efficient devices and strategic planning to
ensure regional and international presence.
Manufacturers are also trying to direct their
attention towards improving these products," says
the FMI Analyst.

• PDL1 Biomarker Testing Market - Important
  Highlights
• PD-L1 SP142 assay kits will account for half the
  market share in terms of value, owing to high
  efficiency in detecting cancer
• Request a report sample to gain more market
  insights at https//www.futuremarketinsights.com/r
  eports/sample/rep-gb-5897

5
PD-L1 Biomarker Testing Market Analysis

• North America will remain a key region as it
  holds almost 50 of the overall market share in
  terms of value.
• Due to soaring prevalence of these diseases,
  non-small cell lung cancer and melanoma is likely
  to hold 50 of the market share.

• PDL1 Biomarker Testing Market - Driving Factors
• Cancer diagnostic and analysis requires major
  testing to detect early-stage non-small cell
  cancer.
• Use of PDL1 marker remains prominent in measuring
  treatment progress and acquiring better or
  accurate results.
• Adoption of PDL1 markers prove to highly
  efficient in revealing mutation and establishing
  protein expression levels to enhance cancer
  treatment.
• Lung cancer patients with adenocarcinoma rely on
  these testers to achieve early-stage progress and
  detection.

6
PD-L1 Biomarker Testing Market Analysis
PDL1 Biomarker Testing Market - Key
Restraints Poor efficiency and precision of
biomarkers might hamper market growth to a great
extent. Constant fluctuations in the result
decelerates market growth and limit PDL1
adoption. For any Queries Linked with the
Report, Ask an Analyst_at_ https//www.futuremarketin
sights.com/ask-question/rep-gb-5897

• Anticipated Market Impact by Coronavirus Outbreak
• The COVID-19 pandemic has had a considerable
  impact on PDL1 biomarker testing market. Reduced
  number of screenings is adversely affecting the
  market growth. According to Cancer Research
  Network, screening rate has decreased by 50 in
  UK and 30 in the United States.
• However, considering the seriousness of these
  diseases, market will not remain sluggish for a
  long period and a recovery is expected in late
  2021.

7
PD-L1 Biomarker Testing Market Analysis
Competition Landscape Key players in the market
include F. Hoffmann-La Roche Ltd, Agilent
Technologies, Inc., NeoGenomics Laboratories,
Inc, HalioDx and Abcam plc. Participants are
focussing on reduction of operational costs and
adoption of organic strategies. Business
strategies like capacity expansion and strategic
partnerships will boost the market growth
globally, thereby, enhancing geographical
presence throughout. Mergers and acquisitions
will lead to a better foothold too.
Buy Now_at_ https//www.futuremarketinsights.com/chec
kout/5897
8
PD-L1 Biomarker Testing Market Analysis
More on the report FMI market research report
presents in-depth insights on PDL1 biomarker
testing market. The foremost objective focusses
on demand generators, and technological
advancements in the market including instrument
precision and services. The report brings to our
notice about the leading manufacturers who are
involved in the market, along with their detailed
profiles. Essential and up-to-date data
information related to key market players are
principally engaged in the production of
inhibitors, have been brought with the help of a
detailed dashboard view.
9
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)